5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.68▲ | 1.68▲ | 1.68▲ | 1.72▼ | 1.45▲ |
MA10 | 1.60▲ | 1.57▲ | 1.55▲ | 1.56▲ | 1.54▲ |
MA20 | 1.49▲ | 1.48▲ | 1.47▲ | 1.40▲ | 2.37▼ |
MA50 | 1.37▲ | 1.32▲ | 1.34▲ | 1.52▲ | 2.71▼ |
MA100 | 1.43▲ | 1.47▲ | 1.47▲ | 2.39▼ | 4.75▼ |
MA200 | 1.55▲ | 1.68▲ | 1.89▼ | 2.63▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.025▲ | 0.029▲ | 0.033▲ | 0.061▲ | -0.025▼ |
RSI | 71.435▲ | 70.142▲ | 69.256▲ | 58.848▲ | 41.945▼ |
STOCH | 93.912▲ | 95.517▲ | 95.873▲ | 86.598▲ | 38.803 |
WILL %R | -4.762▲ | -4.762▲ | -4.762▲ | -16.667▲ | -80.556▼ |
CCI | 96.283 | 103.052▲ | 105.376▲ | 93.232 | -7.893 |
CDL | $SABS Doji Candlestick Pattern Detected | Set Alert |
Saturday, April 05, 2025 05:00 PM
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Free Report) – Research analysts at Chardan Capital raised their FY2025 earnings estimates for shares of SAB Biotherapeutics in a research note issued ...
|
Saturday, April 05, 2025 05:00 PM
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Free Report) – Research analysts at Chardan Capital raised their FY2025 earnings estimates for shares of SAB Biotherapeutics in a research note issued ...
|
Friday, April 04, 2025 06:29 AM
(Reuters) -The tech-heavy Nasdaq Composite index confirmed on Friday that it is in a bear market, after a 22.7% fall from its Dec. 16 record close, as investors fled riskier assets on fears that ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.70 | 1.70 | 1.64 | 1.70 | 9,112 |
30/04/25 | 1.6173 | 1.7814 | 1.58 | 1.70 | 17,635 |
29/04/25 | 1.64 | 1.64 | 1.64 | 1.64 | 11,584 |
28/04/25 | 1.71 | 1.81 | 1.642 | 1.7899 | 32,743 |
25/04/25 | 1.56 | 1.75 | 1.44 | 1.75 | 47,101 |
24/04/25 | 1.38 | 1.50 | 1.335 | 1.50 | 8,198 |
23/04/25 | 1.31 | 1.40 | 1.3015 | 1.37 | 15,427 |
22/04/25 | 1.45 | 1.45 | 1.30 | 1.30 | 37,087 |
21/04/25 | 1.47 | 1.49 | 1.3301 | 1.4259 | 53,700 |
17/04/25 | 1.39 | 1.435 | 1.39 | 1.435 | 869 |
|
|
||||
|
|
||||
|
|